Fig. 2From: Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, SwedenHCV treatment uptake (%) in total, per home region and per year. Treatment year for those treated, year of first positive HCV test for those not treatedBack to article page